查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1929541

分支型胸主动脉血管支架市场（按产品类型、器械类型、移植物材料、输送方式、应用和最终用户划分），全球预测，2026-2032年

Branched Thoracic Stent Grafts Market by Product Type, Device Type, Graft Material, Delivery Mode, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年分支胸主动脉血管支架市场价值为 4.4121 亿美元，预计到 2026 年将成长至 4.7686 亿美元，预计到 2032 年将达到 6.8593 亿美元，复合年增长率为 6.50%。

主要市场统计数据
基准年 2025 4.4121亿美元
预计年份：2026年 4.7686亿美元
预测年份：2032年 6.8593亿美元
复合年增长率 (%) 6.50%

本文简要概述了分支型胸主动脉血管支架创新技术如何改变手术选择、临床工作流程和医疗设施规划。

分支型胸血管支架透过微创、标靶修復主动脉弓及其下游血管，正在重塑复杂主动脉病变的临床治疗模式。器械设计、影像导引部署和输送系统的改进，已使许多手术从开放式手术转向血管内或混合治疗。这一发展体现了技术创新与临床需求的融合。临床医生正在寻求能够减少手术全期併发症、缩短恢復时间，同时维持分支血管通畅性和长期主动脉完整性的解决方案。

临床证据的不断增加、技术转型、监管机构对真实世界数据的重视以及供应链的韧性等因素，是如何改变血管支架这种两极分化的格局的？

分支型胸主动脉血管支架市场格局正经历变革性变化，其驱动力包括技术的成熟、临床实践的改变以及临床医生期望的提升。器械的改进已不再局限于渐进式提升，而是催生了一系列新的手术方案，以应对复杂的主动脉弓解剖结构并提高手术精准度。这些技术主导的变革，加上越来越多的真实世界证据所证实的良好安全性和令人鼓舞的中期疗效，使得越来越多的临床医生认识到，血管内修復是开放手术以外的可行选择。

检验了2025年关税变化对供应链、筹资策略和购买行为的实际、商业和营运影响。

影响关税和贸易的政策趋势会对从事分叉胸主动脉血管支架生产和分销的企业的营运和商业决策产生重大影响。 2025年生效的关税调整为进口组件、成品器械以及手术中常用的专用影像设备带来了新的成本波动。依赖跨境供应链获取原料、组件（如鞘套和输送模组）或专用聚合物化合物的製造商，面临着到岸成本的变化，这些变化已波及到价格谈判、供应商选择和库存策略等各个方面。

将移植体结构、材料科学、临床适应症、临床环境、年龄层和手术方式与决策联繫起来的全面见解

此细分涵盖器材配置、材料科学、临床适应症、医疗机构、患者群体和发行策略，从而提供系统性的观点来解读市场动态和临床决定因素。根据器械类型，此细分市场分为四叉、三叉和二元移植物配置，每种配置都针对不同的解剖结构和手术复杂性。四叉器械适用于需要进行多分支血管重建的全面弓部重组病患。而三叉和二叉设计则用于简化输送、缩短手术时间，同时保留或绕过特定弓部血管的情况。

临床能力、监管管道、采购模式和製造生态系统的区域差异会影响产品应用和商业化策略。

区域差异将从根本上影响分支型胸主动脉血管支架的采用模式、监管参与和商业策略。在美洲，先进的三级医疗中心的临床团队率先采用了分支型技术，多学科团队推动了手术流程和结果报告的改进。对影像基础设施和混合手术室的投资使复杂病例集中在高容量中心进行处理，而培训系统、统一的报销制度和可靠的供应链对于更广泛的应用至关重要。区域法规环境和支付环境将影响器材的上市时间以及医院对新器材平台的投资意愿。

创新和成熟设备製造商的策略竞争策略结合了技术进步、证据累积和适应性商业模式。

分支型胸主动脉血管支架的竞争格局呈现出多元化的特点，既有专业创新型企业，也有成熟的血管器械领导者，还有新兴的区域性製造商。主要企业透过专注于器械工程的投资来脱颖而出，例如低轮廓输送系统、预插管分支导管以及可适应患者个体解剖结构的模组化架构。许多主要参与企业也投入资源，透过建立临床伙伴关係和註册登记合作来累积上市后证据，以展示不同临床环境下的治疗效果。

製造商和医疗保健提供者可以采取哪些切实可行的策略步骤来推动设备创新、确保供应连续性并加速在所有医疗保健机构中的临床应用？

产业领导者应采取整合产品开发、临床伙伴关係和商业性执行的策略，以加速负责任的推广应用，同时保障利润率和业务永续营运。应优先投资于改进设备设计，以降低设备体积和操作复杂性。这些优势将显着扩大目标临床患者群体，并促进其在多种医疗机构中的广泛应用。除了技术改进之外，还应实施完善的临床医生培训计划和基于模拟的课程，以配合技术改进，缩短学习曲线，降低併发症发生率，从而增强推广应用的临床和经济合理性。

我们采用混合调查方法，结合专家访谈、临床文献综述和监管评估，为决策者提供可操作的见解。

本分析所依据的研究采用了混合方法，结合了对关键行业专家、设备工程师和采购专业人员的定性访谈，以及对同行评审的临床文献、手术註册数据和监管指导文件的二次审查。主要资料收集包括对血管外科医生、介入放射科医生和医院管理人员的结构化访谈，以了解手术偏好、实施障碍和培训需求。对製造和供应链专业人员的技术访谈则为评估材料选择、组件采购和生产规模化提供了资讯。

对证据、营运准备和适应策略如何决定分支胸主动脉血管支架的长期整合和价值实现的最终见解

分支型胸主动脉血管支架是治疗复杂主动脉疾病的一项突破性进展，它为开放性手术提供了一种微创替代方案，同时拓展了解剖结构复杂病例的治疗选择。器材创新、影像导航技术的进步以及临床经验的积累，共同推动了手术模式和医疗机构策略的转变。然而，要使这项技术得到广泛应用，必须有可证实的疗效、可复製的培训流程以及稳定的供应链，这些因素都有助于增强临床医生的信心并获得支付方的认可。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 分支型胸主动脉血管支架市场（依产品类型划分）

  • 预製分支胸主动脉血管支架
  • 患者特异性分叉胸主动脉血管支架
  • 模组化配电系统
  • 混合分枝和窗孔结构

第九章 依器械类型分類的分支型胸主动脉血管支架市场

  • 四岔路
  • 三分支型
  • 分叉型

第十章 依移植物材料分類的分支型胸主动脉血管支架市场

  • 聚酯纤维
  • 乙胺类药物

第十一章 以输送方式分類的分支型胸主动脉血管支架市场

  • 血管内治疗
  • 杂交种

第十二章 分支型胸主动脉血管支架市场（依应用领域划分）

  • 主动脉瘤
    • 胸主动脉瘤
    • 腹部主动脉血管瘤
  • 主动脉剥离
    • A型
    • B型

第十三章 分支型胸主动脉血管支架市场（依最终用户划分）

  • 门诊手术中心
    • 医院所有
    • 独立的
  • 医院
    • 私人的
    • 民众
  • 专科诊所

第十四章 分支型胸主动脉血管支架市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 分支型胸主动脉血管支架市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国分支型胸主动脉血管支架市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 美国分支胸主动脉血管支架市场

第十七章：中国分支型胸主动脉血管支架市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AorTech International PLC
  • Aptus Endosystems, Inc.
  • Atrium Medical Corporation
  • Bolton Medical, Inc.
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Cook Vascular
  • CryoLife, Inc.
  • Endospan Ltd.
  • Endovascular Solutions, Inc.
  • Getinge AB
  • Hemoteq AG
  • Innovative Cardiovascular Solutions, Inc.
  • InspireMD Ltd.
  • Jotec GmbH
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Pulsar Vascular Ltd.
  • Terumo Corporation
  • Vascutek Ltd.
  • WL Gore & Associates, Inc.
Product Code: MRR-0A3806951806

The Branched Thoracic Stent Grafts Market was valued at USD 441.21 million in 2025 and is projected to grow to USD 476.86 million in 2026, with a CAGR of 6.50%, reaching USD 685.93 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 441.21 million
Estimated Year [2026] USD 476.86 million
Forecast Year [2032] USD 685.93 million
CAGR (%) 6.50%

A concise orientation to how branched thoracic stent graft innovations are transforming procedural choices, clinical workflows, and institutional planning

Branched thoracic stent grafts are reshaping the clinical approach to complex aortic pathology by enabling less invasive targeted repair of the aortic arch and downstream vessels. Advances in device architecture, imaging-guided deployment, and delivery system refinements have moved many procedures from open surgical repair toward endovascular or hybrid pathways. This evolution reflects a convergence of engineering innovation and clinical demand: clinicians seek solutions that reduce perioperative morbidity and shorten recovery times while preserving branch vessel patency and long-term aortic integrity.

Contemporary devices incorporate features such as pre-cannulated branches, modular configurations, and low-profile sheaths designed to navigate tortuous anatomy. Parallel enhancements in computed tomography angiography, fusion imaging, and intravascular navigation systems have improved pre-procedure planning and intra-procedural accuracy, increasing clinician confidence in treating anatomically challenging cases. As evidence accumulates from registry data and growing clinical series, indications and techniques continue to expand, prompting hospitals, specialty clinics, and ambulatory surgery centers to re-evaluate procedural pathways, capital allocation, and team competencies.

Moreover, the interplay between graft material selection and long-term durability has gained prominence among vascular surgeons and device engineers. Material choice influences graft conformability, suture-line integrity in hybrid procedures, and thrombogenic profile. The device ecosystem now encompasses institutional stakeholders from imaging specialists and perfusion teams to post-anesthesia care units, each influencing adoption and outcomes. Consequently, strategic decisions around investment in branched thoracic stent graft capabilities must account for clinical evidence, operational readiness, and the shifting reimbursement environment that governs procedure selection.

How converging clinical evidence, procedural migration, regulatory emphasis on real-world data, and supply chain resilience are reshaping the branched stent graft landscape

The landscape for branched thoracic stent grafts is undergoing transformative shifts driven by technological maturation, changing care settings, and evolving clinician expectations. Device refinements have progressed beyond incremental improvements to enable a new class of procedures that address complex aortic arch anatomy with improved precision. These technology-led changes are paired with a growing body of real-world evidence demonstrating acceptable safety profiles and encouraging mid-term outcomes, which in turn expands the pool of clinicians who view endovascular repair as a viable alternative to open surgery.

Simultaneously, procedural migration toward less invasive pathways has influenced the distribution of cases across care settings. Ambulatory surgery centers and specialty clinics, particularly those integrated with hospital systems, are increasingly considered for lower-complexity endovascular interventions, while high-acuity or hybrid cases remain concentrated in tertiary hospitals with multidisciplinary teams. This fragmentation of care delivery creates opportunities for device manufacturers to tailor training, delivery profiles, and service models to distinct end-user segments.

Regulatory pathways and post-market surveillance expectations are also shifting. Authorities are placing a stronger emphasis on long-term performance data and real-world evidence generation, prompting manufacturers to invest in registries, procedural training programs, and collaborative research with high-volume centers. Finally, supply chain resilience and component standardization have emerged as pragmatic priorities; scalable manufacturing approaches and strategic supplier partnerships are now integral to sustaining device availability across diverse geographies and care settings. Collectively, these shifts signal a transition from experimental adoption toward mainstream clinical integration contingent on evidence, operational readiness, and stakeholder alignment.

Examining the practical commercial and operational consequences of United States tariff changes in 2025 on supply chains, sourcing strategies, and procurement behavior

Policy developments affecting tariffs and trade can materially influence the operational and commercial calculus for companies involved in branched thoracic stent graft manufacturing and distribution. Tariff adjustments enacted within the United States in 2025 introduced new cost dynamics across imported components, finished devices, and specialized imaging equipment often used in these procedures. Manufacturers that rely on cross-border supply chains for raw materials, components such as sheaths and delivery modules, or specialized polymer compounds encountered changes in landed costs that reverberated through pricing negotiations, vendor selection, and inventory strategies.

In response, several manufacturers implemented mitigation tactics including nearshoring of production, diversification of supplier bases, and renegotiation of long-term procurement contracts to stabilize input costs. Clinical service providers adjusted procurement timelines and engaged in more rigorous cost-benefit assessments when selecting device configurations or opting for single-use versus reusable ancillary equipment. Larger integrated health systems leveraged scale to absorb incremental costs, while smaller centers evaluated procedural volumes and reimbursement adequacy before expanding branched procedure offerings.

These tariff-related shifts also affected collaboration models between manufacturers and clinical partners. Investment in training programs and consignment-based stocking arrangements became more common as manufacturers sought to offset potential demand sensitivity by removing upfront acquisition barriers for facilities. At the same time, payers and hospital procurement committees increased scrutiny of total cost of care metrics, emphasizing long-term outcomes and device durability as central factors in purchasing decisions. Collectively, the tariff-driven adjustments in 2025 accelerated strategic re-alignment across sourcing, pricing, and partnership models within the branched thoracic stent graft ecosystem.

Comprehensive segmentation-driven insights that align graft architecture, material science, clinical indications, care settings, age demographics, and procedural delivery modes to decision-making

Segmentation offers a structured lens to interpret market dynamics and clinical decision drivers across device configurations, material science, clinical indications, care settings, patient demographics, and delivery strategies. Based on Device Type, the field is differentiated across Four Branched, Three Branched, and Two Branched graft architectures, each addressing distinct anatomic scenarios and procedural complexities. Four Branched devices cater to patients requiring comprehensive arch reconstruction with multiple branch revascularizations, whereas Three Branched and Two Branched designs are chosen for configurations that spare or bypass specific arch vessels while simplifying delivery and reducing procedural time.

Based on Graft Material, contemporary options include Dacron and ePTFE, with each material offering specific performance characteristics. Dacron is often valued for its long clinical track record and suture compatibility in hybrid constructs, while ePTFE is selected for its conformability and surface properties that may influence thrombogenicity and integration. Based on Application, clinical use cases split between Aortic Aneurysm and Aortic Dissection. The Aortic Aneurysm category is further considered as Thoracic Aneurysm and Thoracoabdominal Aneurysm, which differ in extent of visceral involvement and therefore in required device length and branch strategy. The Aortic Dissection category is further delineated into Type A and Type B, which carry distinct urgency profiles, anatomic repair targets, and implications for cerebral and visceral protection strategies.

Based on End-User, the procedural context spans Ambulatory Surgery Centers, Hospitals, and Specialty Clinics. Ambulatory Surgery Centers are further characterized by Hospital Owned and Independent models that influence capital access and case mix, while Hospitals are subdivided into Private and Public institutions that present different procurement cycles and payer interactions. Based on Patient Age Group, clinical pathways are analyzed across 18-45, 46-65, and 65+, each cohort presenting varying comorbidity burdens, anatomical considerations, and risk tolerance. Based on Delivery Mode, interventions are categorized as Endovascular and Hybrid approaches; endovascular solutions emphasize percutaneous access and modular deployment, whereas hybrid approaches integrate open surgical maneuvers with endovascular grafting to manage complex landing zones or provide cerebral protection. Synthesizing these segmentation perspectives enables targeted clinical strategies, differentiated product design priorities, and tailored commercial approaches that align with the nuanced needs of each subpopulation and care setting.

How regional differences in clinical capacity, regulatory pathways, purchasing models, and manufacturing ecosystems influence adoption and commercialization strategies

Regional variation fundamentally shapes adoption patterns, regulatory engagement, and commercial strategy for branched thoracic stent grafts. In the Americas, clinical communities in advanced tertiary centers have been early adopters of branched technologies, with multidisciplinary teams driving procedural refinement and outcomes reporting. Investment in imaging infrastructure and hybrid operating suites supports a concentration of complex cases in high-volume centers, while broader diffusion depends on training, reimbursement alignment, and supply chain reliability. The region's regulatory and payer environments influence device introduction timelines and the willingness of institutions to invest in newer device platforms.

Europe, Middle East & Africa presents a heterogeneous landscape where national regulatory pathways, hospital funding models, and practice patterns vary significantly. In some European markets, centralized procurement and health technology assessment frameworks necessitate robust clinical evidence and health economic justification for broader adoption. In the Middle East and Africa, demand is often concentrated in urban tertiary hospitals that serve as regional centers of excellence and that may facilitate rapid uptake of advanced device platforms when supported by skilled multidisciplinary teams.

Asia-Pacific encompasses markets with a wide spectrum of maturity in endovascular capabilities. Several markets within the region have active device development and manufacturing ecosystems, creating opportunities for localized production and cost-competitive offerings. Meanwhile, clinical adoption in major urban centers is supported by strong procedural volumes and growing investment in hybrid and endovascular operating rooms. Across all regions, regional collaboration, training initiatives, and registry participation play pivotal roles in harmonizing standards of care and accelerating responsible adoption of branched thoracic stent graft technology.

Strategic competitive approaches from innovators and established device manufacturers that combine engineering advances, evidence generation, and adaptable commercial models

The competitive environment for branched thoracic stent grafts is characterized by a mix of specialized innovators, established vascular device leaders, and emerging regional manufacturers. Key companies differentiate through focused investments in device engineering, such as low-profile delivery systems, pre-cannulated branch conduits, and modular architectures that accommodate patient-specific anatomy. Many leading players are also committing resources to post-market evidence generation, forming clinical partnerships and registry collaborations to demonstrate outcomes across diverse practice settings.

Strategic differentiators include integrated training programs that help clinicians shorten learning curves, consignment and leasing models that lower acquisition friction for hospitals, and bundled support services that encompass imaging optimization and procedural planning. Several companies are expanding their value proposition by offering digital tools for pre-operative planning, including patient-specific simulation and three-dimensional modeling, which increase procedural predictability and facilitate surgeon adoption. Moreover, manufacturing scale and supplier relationships are central to ensuring consistent device availability and cost control, particularly in the wake of supply chain pressures.

Emerging entrants and regional manufacturers are challenging incumbents on price and localized support, prompting established firms to highlight clinical outcomes, long-term durability, and comprehensive service offerings. Collaboration between industry and high-volume clinical centers continues to drive iterative product improvements and broaden indications. In this environment, the most successful companies will balance technical innovation with scalable service models, robust clinical evidence, and adaptable commercial strategies that respond to regional and institutional variability.

Practical strategic measures for manufacturers and providers to drive device innovation, secure supply continuity, and accelerate clinical adoption across care settings

Industry leaders should pursue integrated strategies that align product development, clinical partnerships, and commercial execution to accelerate responsible adoption while protecting margins and operational resilience. Prioritize investments in device design refinements that reduce profile and procedural complexity, as these attributes materially improve the addressable clinical population and facilitate broader uptake across care settings. Complement engineering improvements with robust clinician training programs and simulation-based curricula to shorten learning curves and reduce complication rates, thereby strengthening the clinical and economic case for adoption.

Mitigate supply chain and regulatory risks by diversifying suppliers, exploring localized manufacturing partnerships, and proactively engaging with regulatory authorities to align post-market data requirements. Where tariffs or trade policy create cost uncertainty, adopt flexible procurement models such as consignment inventory, leasing, or outcome-based contracting to preserve purchasing momentum among hospital systems and specialty centers. Strengthen evidence generation through multi-center registries and collaborative outcomes research that emphasize real-world safety and durability while addressing health economic questions relevant to payers.

Commercially, tailor go-to-market approaches to the segmentation dynamics described earlier: deploy focused strategies for Four Branched, Three Branched, and Two Branched device pathways; highlight material-specific benefits for Dacron and ePTFE grafts; and align messaging to end-user types including hospital-owned and independent ambulatory surgery centers. Finally, invest in digital planning tools and data analytics that support personalized device selection and demonstrate value to clinicians and procurement stakeholders. These combined actions will help industry leaders sustain innovation momentum while delivering predictable clinical and economic outcomes.

A mixed-methods research approach combining expert interviews, clinical literature synthesis, and regulatory evaluation to produce actionable insights for decision-makers

The research underpinning this analysis employed a mixed-methods approach combining primary qualitative interviews with key opinion leaders, device engineers, and procurement specialists, alongside secondary review of peer-reviewed clinical literature, procedural registries, and regulatory guidance documents. Primary data collection included structured interviews with vascular surgeons, interventional radiologists, and hospital administrators to capture procedural preferences, adoption barriers, and training needs. Technical interviews with manufacturing and supply chain experts informed assessments of material choices, component sourcing, and production scalability.

Secondary research focused on published clinical series, consensus statements, and guidance from major surgical societies to synthesize current standards of care and procedural best practices. Regulatory frameworks across major regions were examined to compare approval pathways, post-market surveillance expectations, and health technology assessment considerations. Where appropriate, case studies of procurement and implementation at leading centers were analyzed to identify operational enablers and common pitfalls.

Findings were triangulated across data sources to ensure consistency and to highlight areas of divergence. Emphasis was placed on evidence quality, clinical relevance, and operational applicability. Limitations of the methodology, such as the evolving nature of long-term outcome data and the variability of national reimbursement environments, were acknowledged and factored into the analysis. The resulting insights are intended to be actionable for strategic planners, clinical leaders, and commercial teams seeking to navigate the complex ecosystem surrounding branched thoracic stent graft adoption.

Concluding perspectives on how evidence, operational readiness, and adaptive strategies will determine the long-term integration and value realization of branched thoracic stent grafts

Branched thoracic stent grafts represent a pivotal advancement in the management of complex aortic disease, offering less invasive alternatives to open repair while expanding therapeutic options for anatomically challenging cases. The convergence of device innovation, enhanced imaging and navigation technologies, and accumulating clinical experience has catalyzed a shift in procedural paradigms and institutional strategies. However, adoption is contingent on demonstrable outcomes, reproducible training pathways, and supply chain stability that together underpin clinician confidence and payer acceptance.

Regional differences, material science considerations, and device architecture choices all influence clinical decision-making and commercial strategy. The combined impact of regulatory scrutiny, tariff dynamics, and evolving care delivery models demands that stakeholders adopt flexible, evidence-driven approaches. For manufacturers, this means investing in meaningful clinical partnerships and scalable manufacturing practices. For providers, it means carefully aligning procedural capabilities with institutional resources and patient selection priorities.

Ultimately, the trajectory of branched thoracic stent graft adoption will be shaped by the quality of long-term evidence, the effectiveness of training and planning tools to reduce procedural variability, and the ability of the ecosystem to adapt to policy and supply chain shocks. Stakeholders who integrate these elements into cohesive strategies will be best positioned to translate technological promise into consistent clinical value and sustainable program growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Branched Thoracic Stent Grafts Market, by Product Type

  • 8.1. Off-the-Shelf Branched Thoracic Stent Grafts
  • 8.2. Patient-Specific Branched Thoracic Stent Grafts
  • 8.3. Modular Branched Systems
  • 8.4. Hybrid Branched-Fenestrated Constructs

9. Branched Thoracic Stent Grafts Market, by Device Type

  • 9.1. Four Branched
  • 9.2. Three Branched
  • 9.3. Two Branched

10. Branched Thoracic Stent Grafts Market, by Graft Material

  • 10.1. Dacron
  • 10.2. Eptfe

11. Branched Thoracic Stent Grafts Market, by Delivery Mode

  • 11.1. Endovascular
  • 11.2. Hybrid

12. Branched Thoracic Stent Grafts Market, by Application

  • 12.1. Aortic Aneurysm
    • 12.1.1. Thoracic Aneurysm
    • 12.1.2. Thoracoabdominal Aneurysm
  • 12.2. Aortic Dissection
    • 12.2.1. Type A
    • 12.2.2. Type B

13. Branched Thoracic Stent Grafts Market, by End-User

  • 13.1. Ambulatory Surgery Centers
    • 13.1.1. Hospital Owned
    • 13.1.2. Independent
  • 13.2. Hospitals
    • 13.2.1. Private
    • 13.2.2. Public
  • 13.3. Specialty Clinics

14. Branched Thoracic Stent Grafts Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Branched Thoracic Stent Grafts Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Branched Thoracic Stent Grafts Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Branched Thoracic Stent Grafts Market

18. China Branched Thoracic Stent Grafts Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AorTech International PLC
  • 19.6. Aptus Endosystems, Inc.
  • 19.7. Atrium Medical Corporation
  • 19.8. Bolton Medical, Inc.
  • 19.9. Cardinal Health, Inc.
  • 19.10. Cook Medical LLC
  • 19.11. Cook Vascular
  • 19.12. CryoLife, Inc.
  • 19.13. Endospan Ltd.
  • 19.14. Endovascular Solutions, Inc.
  • 19.15. Getinge AB
  • 19.16. Hemoteq AG
  • 19.17. Innovative Cardiovascular Solutions, Inc.
  • 19.18. InspireMD Ltd.
  • 19.19. Jotec GmbH
  • 19.20. Medtronic plc
  • 19.21. MicroPort Scientific Corporation
  • 19.22. Nipro Corporation
  • 19.23. Pulsar Vascular Ltd.
  • 19.24. Terumo Corporation
  • 19.25. Vascutek Ltd.
  • 19.26. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY OFF-THE-SHELF BRANCHED THORACIC STENT GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY OFF-THE-SHELF BRANCHED THORACIC STENT GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY OFF-THE-SHELF BRANCHED THORACIC STENT GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT-SPECIFIC BRANCHED THORACIC STENT GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT-SPECIFIC BRANCHED THORACIC STENT GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT-SPECIFIC BRANCHED THORACIC STENT GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY MODULAR BRANCHED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY MODULAR BRANCHED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY MODULAR BRANCHED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID BRANCHED-FENESTRATED CONSTRUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID BRANCHED-FENESTRATED CONSTRUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID BRANCHED-FENESTRATED CONSTRUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY FOUR BRANCHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY FOUR BRANCHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY FOUR BRANCHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THREE BRANCHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THREE BRANCHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THREE BRANCHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TWO BRANCHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TWO BRANCHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TWO BRANCHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DACRON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DACRON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DACRON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY EPTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY EPTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY EPTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY ENDOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY ENDOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY ENDOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE A, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE A, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE A, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE B, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE B, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE B, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITAL OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITAL OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 189. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 192. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 193. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 194. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 222. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 225. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 226. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 227. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 229. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 233. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 236. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 237. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 238. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 239. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)